Disruption of the axis stimulates antigen-presenting cells (APC)—specifically CD8+/CD103 + dendritic cells—and cross-presentation of tumor antigen, resulting in priming or reactivation of tumor-specific T-cell immunity. This evidence concerns the gene CD8A and neoplasm.